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Abstract
Background: Persistent infections that induce prolonged inflammation might negatively affect the leukocyte
telomere length (LTL); however, the role in LTL of Helicobacter pylori (H. pylori) infection, which persistently colonizes
the stomach, remains unknown.
The study objective was to examine associations of sero-prevalence of H. pylori immunoglobulin G (IgG) antibody
and serum pepsinogens (PGs), as markers of atrophic gastritis, with LTL.
A cross-sectional study was performed among 934 Arab residents of East Jerusalem, aged 27–78 years, randomly
selected from Israel’s national population registry. Sera were tested for H. pylori IgG and PG levels by ELISA. LTL was
measured by southern blots. Multiple linear regression models were fitted to adjust for sociodemographic and
lifestyle factors.
Results: LTL decreased significantly with age (p < 0.001) and was shorter in men than women (p = 0.032). The mean LTL
was longer in H. pylori sero-positive persons than negative ones: mean difference 0.13 kb (95% CI 0.02, 0.24), p = 0.016.
Participants with atrophic gastritis (PGI < 30 μg/L or a PGI: PGII < 3.0) had shorter LTL than did those without: mean
difference − 0.18 (95% CI − 0.32, − 0.04). The difference was of larger magnitude between persons who had past H. pylori
infection (sero-negative to H. pylori IgG antibody) and atrophic gastritis, compared to those who were H. pylori sero-
negative and did not have atrophic gastritis: mean difference − 0.32 kb (95% CI − 0.55, − 0.10). This association remained
significant after adjustment for age, sex, and religiosity: beta coefficient − 0.21 kb (95% CI − 0.41, − 0.001), p = 0.049. The
results were similar after further adjustment for lifestyle factors. In bivariate analysis, mean LTL was longer in physically
active persons than non-active ones, and shorter in persons with than without obesity; however, these differences were
diminished and were not significant in the multivariable model.
Conclusions: H. pylori IgG sero-positivity per se was not related to reduced LTL. However, persons with past H. pylori
infection (i.e., lacking H. pylori IgG serum antibody) and with serological evidence of atrophic gastritis, had a significantly
shorter LTL than did those without atrophic gastritis.
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Background
Telomeres are repetitive nucleotides at the ends of
eukaryotic chromosomes [1, 2] that are essential for gen-
omic stability. Telomere length shortens with every cell
division, due to the inability of DNA polymerase to extend
DNA ends [1, 3]. Telomeres that shorten beyond a critical
level cause cellular senescence [1, 3]; thus, telomere length
has a considerable impact on human health [4].
Leukocyte telomere length (LTL) is commonly
assessed in epidemiological studies [4]. LTL is affected
by heredity [5, 6]; decreases with age [5, 7, 8]; is longer
in females than males [7, 8]; correlates positively with
paternal age at conception [6]; and varies by race, being
longer, for example, in persons of African ancestry than
individuals of European ancestry [4, 7, 9].
Shorter LTL was consistently linked to increased risk
of atherosclerosis [10–15] and reduced survival [16–18].
The association between LTL and cancer risk is less con-
sistent [19]. Some studies showed an increased risk for
cancer in relation to short LTL [20, 21], while in other
studies longer LTL was associated with increased cancer
risk [22]. Given the importance of telomere length in
human health, searching for modifiable determinants of
LTL is highly desirable. Persons of low socioeconomic
status displayed shorter LTL than did persons of high
socioeconomic status [23]. Smokers were found to have
shorter LTL than never or former smokers [24, 25].
Obesity [25] and higher body mass index (BMI) [26]
were associated with shorter telomeres [26], while a
positive association was found of physical activity with
telomere length [27, 28]. An inverse association was
shown between dietary caloric intake and LTL in men
[29]. Persistent infections have been suggested to play a
role in telomere length through the induction of oxida-
tive stress and inflammation [30, 31]. For example, asso-
ciations were reported of exposure to cytomegalovirus
(CMV), herpes simplex virus type 1 (HSV-1), and hu-
man herpes virus 6 with greater LTL attrition in healthy
adults [31], although these associations were not affected
by systemic non-specific inflammatory markers such as
C-reactive protein and interleukin 6 [31]. If infectious
agents are truly associated with LTL, associations would
be expected between tissue damage induced by these
pathogens and LTL. Helicobacter pylori (H. pylori), a
gram-negative bacterium that colonizes the stomach,
can serve as a model to examine this hypothesis. H.
pylori infection is acquired in childhood [32]. While H.
pylori cause chronic gastritis in almost all infected per-
sons, some present with peptic ulcers and gastric cancer
in adulthood, especially those infected with strains that
express cytotoxin-associated gene A (CagA) virulence
antigen (reviewed in [33, 34]). Pepsinogen I (PGI) and
PGII, pro-enzymes of pepsin, are secreted into the gas-
tric lumen, and small amounts can be found in the
serum [35, 36]. With increasing severity of H. pylori
gastritis, serum PGI and PGII levels increase, but when
atrophic gastritis ensues, the PGI level and the PGI:PGII
ratio decrease. Serum PGs can predict atrophic gastritis
and gastric cancer [37–41]. The objective of the current
study was to examine associations of the sero-prevalence
of H. pylori immunoglobulin G (IgG) antibody and
serological evidence of atrophic gastritis with LTL in a
general population sample.
Results
Description of the study sample
Overall, 934 participants (53.1% men) were tested for
both H. pylori IgG antibody and LTL. The age at exam-
ination ranged from 27.0 to 78.0 years, with a mean of
52.0 years (standard deviation [SD] 13.9), which was
similar among men and women. Most (64.2%) partici-
pants had not completed high school; this was more true
for women (70.3%) than men (58.8%). Most participants
(62.4%) defined themselves as traditional/secular: 67.5%
and 56.6% in men and women, respectively. Overall,
82.0% of the participants reported being married; 94.2%
and 68.1% among men and women, respectively. The
overall prevalence of smoking was 26.0%: 40.8% in men
and 9.0% in women; the respective figures for obesity
were 44.1%, 31.9%, and 58.0% (Table 1).
Mean LTL according to demographic and lifestyle factors
The LTL values ranged from 4.72 kb to 8.53 kb, with a
mean of 6.76 kb (SD 0.61). The mean LTL was longer in
women than men (p = 0.073). The mean LTL was longest
in the youngest age group (27–34 years), 7.18 kb (SD
0.55), and decreased progressively in older age groups,
reaching 6.40 kb (SD 0.55) at age 65–78 years (p < 0.001).
All pairwise comparisons between the age groups were
statistically significant by the Bonferroni test. The mean
LTL differed significantly (p = 0.007) according to educa-
tion, with a mean 6.72 kb (SD 0.58) among participants
who had not completed high school, 6.83 kb (SD 0.61) in
those who had completed high school (p = 0.055 by the
Bonferroni test), and 6.87 kb (SD 0.71) in participants with
academic education (p = 0.033 by the Bonferroni test).
Persons who defined themselves as religious had shorter
mean LTL than persons who defined themselves as
traditional or secular (p < 0.001). Married individuals
had longer mean LTL than unmarried ones: mean dif-
ference 0.11 (95% confidence intervals [CI] 0.01, 0.21),
p = 0.039. Persons with obesity had shorter mean LTL,
6.71 kb (SD 0.60), than persons without obesity, 6.80 kb
(SD 0.62), (p = 0.025). Physically active persons had
longer mean LTL than non-active ones (p < 0.001); this
association was found both for physical activity that
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was defined as sufficient and as high level. Mean LTL was
not found to differ significantly according to the number of
siblings (p = 0.2) and smoking (p = 0.6) (Table 2). Differ-
ences in the expected directions in mean LTL, according to
age, religiosity, obesity, and high level of physical activity
were observed in both men and women. In women, mean
LTL differed significantly (p = 0.001) according to educa-
tional level, being the longest among those with academic
education; but such difference was not significant (p = 0.3)
in men (p for interaction 0.2). The difference in mean LTL
according to marital status was significant in women only
(p for interaction 0.009). The difference in mean LTL
according to a modest level of physical activity level was
significant among women only (p for interaction 0.07). No
significant interactions were found between the other inde-
pendent variables and sex (see Additional file 1).
Table 1 Characteristics of the study sample
Overall, n (%) Men, n (%) Women, n (%)
Total 934 496 438
Mean age, years, (SD) 52.0 (13.9) 51.9 (14.0) 52.0 (13.8)
Age groups, years
27–34 127 (13.6) 71 (14.3) 56 (12.8)
35–44 191 (20.4) 97 (19.6) 94 (21.5)
45–54 205 (21.9) 110 (22.2) 95 (21.7)
55–64 195 (20.9) 100 (20.2) 95 (21.7)
65–78 216 (23.1) 118 (23.8) 98 (22.3)
Education
Did not complete high school 598 (64.2) 291 (58.8) 307 (70.2)
Completed high school 210 (22.5) 118 (23.8) 92 (21.1)
Academic education 124 (13.3) 86 (17.4) 38 (8.7)
Number of siblings
0–3 87 (9.3) 45 (9.1) 42 (9.6)
4–7 423 (45.3) 222 (44.8) 201 (45.9)
≥ 8 423 (45.3) 228 (46.1) 195 (44.5)
Religiosity
Religious 350 (37.6) 161 (32.5) 189 (43.4)
Traditional/secular 580 (62.4) 334 (67.5) 246 (56.6)
Marital status*
Married 764 (82.0) 467 (94.2) 297 (68.1)
Not married 168 (18.0) 29 (5.8) 139 (31.9)
Smoking
≥ 1 cigarettes/day 241 (26.0) 202 (40.8) 39 (9.0)
No smoking/other 687 (74.0) 293 (59.2) 394 (91.0)
Obesity
BMI < 30 kg/m2 522 (55.9) 338 (68.1) 184 (42.0)
BMI ≥ 30 kg/m2 412 (44.1) 158 (31.9) 254 (58.0)
Sufficient physical activity level
No 180 (19.3) 68 (13.7) 112 (25.6)
Yes 754 (80.7) 428 (86.3) 326 (74.4)
High physical activity level
No 265 (28.4) 111 (22.4) 154 (35.2)
Yes 669 (71.6) 385 (77.6) 284 (64.8)
BMI body mass index; SD standard deviation
*Not married included persons who defined themselves as single, divorced, or widowed
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H. pylori sero-status, atrophic gastritis, and LTL
H. pylori IgG sero-positivity was found in 780/934
(83.4%) participants and atrophic gastritis in 81/927
(8.7%). In persons with a past H. pylori infection (lacked
H. pylori IgG serum antibody), atrophic gastritis was
found in 37 (4.0%), atrophic gastritis and H. pylori sero-
positivity was evident in 44 (4.7%), and H. pylori sero-
positivity without serological evidence of atrophic
Table 2 Mean leukocyte telomere length (kb) according to sociodemographic and lifestyle factors
Total Mean (SD) Mean difference (95% CI) p value
Sex 0.073
Men 496 6.73 (0.63) − 0.07 (− 0.15, 0.01)
Women 438 6.80 (0.59) Reference
Age, years df = 4 < 0.001*
27–34 127 7.18 (0.55) Reference
35–44 191 7.00 (0.54) − 0.18 (− 0.36, − 0.01)
45–54 205 6.80 (0.55) − 0.39 (− 0.56, − 0.21)
55–64 195 6.62 (0.56) − 0.57 (− 0.75, − 0.39)
65–78 216 6.40 (0.55) − 0.78 (− 0.96, − 0.61)
Education df = 2 0.007**
Did not complete high school or less 598 6.72 (0.58) Reference
Completed high school 210 6.83 (0.61) 0.11 (− 0.002, 0.23)
Academic education 124 6.87 (0.71) 0.15 (0.01, 0.30)
Number of siblings df=2 0.2***
0–3 87 6.67 (0.60) Reference
4–7 423 6.75 (0.63) 0.08 (− 0.09, 0.25)
≥ 8 423 6.79 (0.59) 0.12 (− 0.05, 0.30)
Religiosity < 0.001
Religious 350 6.67 (0.61) − 0.15 (− 0.23, − 0.07)
Traditional/secular 580 6.82 (0.60) Reference
Marital status**** 0.039
Married 764 6.78 (0.62) 0.11 (0.01, 0.21)
Not married 168 6.67 (0.56) Reference
Smoking 0.6
≥ 1 cigarettes/day 241 6.78 (0.59) 0.02 (− 0.07, 0.11)
No smoking/other 687 6.76 (0.62) Reference
Obesity 0.025
BMI < 30 kg/m2 522 6.80 (0.62) 0.09 (0.01, 0.17)
BMI ≥ 30 kg/m2 412 6.71 (0.60) Reference
Sufficient physical activity level
No 180 6.60 (0.59) − 0.20 (− 0.29, − 0.10) < 0.001
Yes 754 6.80 (0.61) Reference
High physical activity level < 0.001
No 265 6.62 (0.61) − 0.20 (− 0.30, − 0.10)
Yes 669 6.82 (0.60) Reference
BMI body mass index; CI confidence intervals; df degrees of freedom
*ANOVA for the difference between the groups. Bonferroni test 27–34 vs. 35–44 (p = 0.035), 45–54 vs. 55–64 (p = 0.013), p < 0.01 for all other pairwise
comparisons between the age groups
**ANOVA for the difference between the groups. Bonferroni test: did not complete high school vs. completed high school (p = 0.055). Did not complete high
school vs. academic degree (p = 0.033). Completed high school vs. academic education (p = 1.0)
***ANOVA for the difference between the groups. Bonferroni test p > 0.2 for all pairwise
****Not married included persons who reported being single, widowed, or divorced
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gastritis in 731 (78.9%), while 115 (12.4%) tested negative
for H. pylori and lacked serological evidence for atrophic
gastritis
The mean LTL was longer in H. pylori IgG sero-posi-
tive persons than in sero-negative ones: 6.78 kb (SD
0.59) vs. 6.65 kb (SD 0.66), p = 0.016; the difference was
significant only when comparing H. pylori sero-positive
persons who had CagA IgG serum antibody with those
who were sero-negative (p = 0.018 by Bonferroni test).
Participants who had serological evidence of atrophic
gastritis had significantly shorter LTL (6.60 kb [SD 0.65])
than did participants without atrophic gastritis: 6.78 kb
(SD 0.60) (p = 0.011). The shortest LTL was found in
participants who had past H. pylori infection (sero-nega-
tive to H. pylori IgG antibody) and atrophic gastritis
(6.40 kb [SD 0.67]); this compared to persons who were
H. pylori sero-negative without atrophic gastritis (6.72
kb [SD 0.63]), those who were H. pylori sero-positive
without atrophic gastritis (6.79 kb [SD 0.60]), and those
who were H. pylori sero-positive with atrophic gastritis
(p = 0.028, p = 0.001, and p = 0.037, respectively, by the
Bonferroni test) (Table 3).
A multiple linear regression model that included the
variable H. pylori sero-status/atrophic gastritis and
adjusted for age, sex, and religiosity was statistically sig-
nificant (F statistic = 26.24, p < 0.001) with an adjusted
R2 of 0.198 (Table 4). This model showed an inverse
dose-response relationship between age and LTL, and
significantly shorter LTL in men than in women; beta
coefficient − 0.08 kb (95% CI − 0.15, − 0.01), p = 0.032.
Compared to participants who were H. pylori sero-nega-
tive without atrophic gastritis, those with past H. pylori
infection (sero-negative to H. pylori IgG antibody) and
with atrophic gastritis had shorter LTL: beta coefficient
− 0.21 kb (95% CI − 0.41, − 0.001), p = 0.049; the differ-
ence was not significant in H. pylori sero-positive per-
sons either with (p = 0.10) or without atrophic gastritis
(p = 0.3). The mean LTL was shorter in religious than
traditional/secular participants; beta coefficient − 0.07 kb
(95% CI − 0.14, 0.01), p = 0.078 (Table 4). The values of
variance inflation factor (VIF) in this model ranged from
1 to 2, suggesting no collinearity.
An additional model that included the variable H.
pylori/atrophic gastritis sero-status and the following
covariates; age, sex, religiosity, education, marital status,
number of siblings, smoking, obesity, and physical
activity showed similar results with regard to the associ-
ations of age, sex, and H. pylori/atrophic gastritis sero-
status with LTL (see Additional file 2). However, no
significant differences in LTL were observed according
to obesity (p = 0.6), smoking (p = 0.7), physical activity
(p = 0.5), marital status (p = 0.8), number of siblings, or
education. The adjusted R2 of this model was 0.193, (F
statistic = 13.86, p < 0.001). The VIF values ranged from
Table 3 Mean leukocyte telomere length (kb) according to H. pylori sero-status and serological evidence of atrophic gastritis
Total Mean (SD) Mean difference (95% CI) p value
H. pylori IgG sero-status 0.016*
H. pylori negative 154 6.65 (0.66) Reference
H. pylori positive 780 6.78 (0.60) 0.13 (0.02, 0.24)
H. pylori/CagA IgG sero-status df = 2 0.023**
H. pylori negative 154 6.65 (0.66) Reference
H. pylori positive CagA negative 452 6.76 (0.60) 0.1 (− 0.01, 0.22) 0.19***
H. pylori positive CagA positive 328 6.82 (0.59) 0.16 (0.05, 0.28) 0.018***
Atrophic gastritis (PGI < 30 μg/L or PGI:PGII < 3.0)§ 0.011*
No 846 6.78 (0.60) − 0.18 (− 0.32, − 0.04)
Yes 81 6.60 (0.65) Reference
H. pylori sero-status/atrophic gastritis**** § df = 3 0.002**
H. pylori negative no atrophic gastritis 115 6.72 (0.63) Reference
H. pylori positive no atrophic gastritis 731 6.79 (0.60) 0.07 (− 0.05, 0.18) 1.0****
H. pylori positive plus atrophic gastritis 44 6.77 (0.58) 0.05 (− 0.16, 0.26) 1.0****
Past H. pylori infection (IgG sero-negatives) plus atrophic gastritis 37 6.40 (0.67) − 0.32 (− 0.55, − 0.10) 0.028****
CagA cytotoxin-associated gene A; CI confidence intervals; df degrees of freedom; IgG immunoglobulin G; PG pepsinogen; SD standard deviation
*p value by Student’s t test
**ANOVA for the difference between the groups
***Bonferroni for multiple comparisons correction compared to H. pylori-negative participants
****Bonferroni for multiple comparisons correction compared to participants who were H. pylori negative and no atrophic gastritis. H. pylori positive no atrophic
gastritis vs. past H. pylori infection plus atrophic gastritis (p = 0.001). H. pylori positive plus atrophic gastritis vs. past H. pylori infection (IgG sero-negatives) plus
atrophic gastritis (p = 0.037)
§Information on atrophic gastritis was missing for 7 participants
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1 to 2, suggesting no collinearity. No significant interac-
tions were found between H. pylori-atrophic gastritis
sero-status with sex (p = 0.2), age (p = 0.12), education
(p = 0.11), obesity (p = 0.2), physical activity (p = 0.12),
and smoking (p = 0.8). Therefore, the interaction terms
were excluded from the final model.
Discussion
We examined associations of H. pylori IgG antibody
sero-positivity and serological evidence of atrophic
gastritis with LTL in a general Arab population sample
while assessing the role of sociodemographic and life-
style factors.
As expected, a significantly shorter LTL was observed
in older vs. younger participants and in men vs. women,
thus confirming previous findings [5, 7, 8]. Exposure to
H. pylori infection per se was not associated with shorter
LTL. On the contrary, H. pylori IgG sero-positivity, espe-
cially CagA phenotype, was associated with longer LTL.
Serological evidence of atrophic gastritis was associated
with shorter LTL, the difference was driven by partici-
pants who tested negative to H. pylori but had atrophic
gastritis. The longer LTL in H. pylori sero-positive
participants can be explained by the higher prevalence
of serological evidence of atrophic gastritis among H.
pylori seronegative participants (24.1%) compared to
those who were H. pylori seropositive, regardless of
whether they were negative or positive for CagA IgG
antibody: 5.7% and 6.0%, respectively, (p < 0.001) [42].
Likely, participants who were H. pylori sero-negative,
but had atrophic gastritis, represent patients with the
most severe form of gastric atrophy, which resulted in
the loss of H. pylori infection [43]. Hence, H. pylori
might negatively affect LTL only in a subset of infected
persons, those with the most severe form of gastric atro-
phy. These findings confirm our general hypothesis that
markers of tissue damage induced by H. pylori are re-
lated to shorter LTL. The longer duration of H. pylori in-
fection observed in older persons is congruent with the
acquisition of the infection in early childhood [32, 44],
and its persistence [45], unless treated. H. pylori infec-
tion causes gastritis and typically, with aging, the severity
of gastritis increases and atrophic lesions develop in the
stomach. The prevalence of atrophic gastritis increases
with age [42]. Hence, our findings might also suggest
that infection of longer duration might decrease LTL;
nonetheless, such interpretation should be made with
caution, since information on the time in which the
infection was acquired is not available.
On the first impression, our results might seem to
contradict our expectations. In fact, our findings fit well
with the natural history of H. pylori infection, indicating
that despite the high prevalence of H. pylori infection of
44% globally [46], generally H. pylori does not cause
Table 4 Multiple linear regression model of adjusted associations of demographic factors, H. pylori sero-status, and serological
evidence of atrophic gastritis with leukocyte telomere length (kb)
Beta coefficient (95% CI) p value
Sex




35–44 − 0.19 (− 0.31, − 0.06) 0.003
45–54 − 0.39 (− 0.51, − 0.26) < 0.001
55–64 − 0.56 (− 0.69, − 0.44) < 0.001
65–78 − 0.76 (− 0.89, − 0.64) < 0.001
Religiosity
Religious − 0.07 (− 0.14, 0.01) 0.078
Traditional/secular Reference
H. pylori sero-status/atrophic gastritis*
H. pylori negative no atrophic gastritis Reference
H. pylori positive no atrophic gastritis 0.05 (− 0.06, 0.16) 0.3
H. pylori positive plus atrophic gastritis 0.16 (− 0.03, 0.35) 0.10
Past H. pylori infection (IgG sero-negatives) plus atrophic gastritis − 0.21 (− 0.41, − 0.001) 0.049
CI confidence intervals; IgG immunoglobulin G
*Atrophic gastritis was defined as serum pepsinogen (PG) I < 30 μg/L or PGI:PGII < 3.0
Model summary: adjusted R2 = 0.198, degrees of freedom = 9, (F statistic = 26.24), p < 0.001
Adjusted for the variables in the table
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disease, and only some infected persons develop peptic
disease and gastric cancer (reviewed in [34]). The magni-
tude of the difference in LTL between persons with past
H. pylori infection and atrophic gastritis and those who
are H. pylori sero-negative and lacking atrophic gastritis
was large (unadjusted mean difference − 0.32 kb [95% CI
− 0.55, − 0.10]), p = 0.028. After adjustment for age, sex,
and religiosity, the association was slightly attenuated
but remained significant (beta coefficient − 0.21 kb [95%
CI − 0.41, − 0.001]), p = 0.049. A case-control study of
gastric cancer in Poland showed an increased risk for
gastric cancer in relation to short LTL [47]. The same
study showed among the control group, shorter LTL in
persons positive than negative for H. pylori [47]. A study
of non-neoplastic gastric mucosa from 106 cancer-free
persons linked epigenetic changes, namely, H. pylori re-
lated hypermethylation of the promoter CpG island, with
increased severity of gastritis and the development of
atrophy (as measured by the PGI:PGII ratio); while
shortened telomere increased the risk for hypermethyla-
tion [48]. Collectively, these and our observations shed
light on the development of damage to the gastric mu-
cosa in relation to H. pylori infection, in which telomere
length shortening seems to play an important role. A
small cross-sectional study of 163 US adults that exam-
ined associations of sero-positivity to four persistent
pathogens (CMV, HSV-1, H. pylori, and Chlamydia
pneumoniae) with total pathogen burden on LTL,
showed reduced LTL in relation to CMV sero-positivity
and increased pathogen burden in women (n = 100) but
not in men (n = 63) [30]. LTL did not differ significantly
according to H. pylori infection and no markers of atro-
phic gastritis were assessed [30]. Elsewhere, among ~
400 participants aged 53–76 years, no significant associ-
ation was found between CMV IgG sero-prevalence and
LTL [49], but telomerase activity was reduced in relation
to CMV positivity. Taken together, these and our find-
ings suggest that exposure to persistent infections might
play a role in LTL. Our findings suggest that strong
specific inflammation of the stomach, as typically in-
duced by H. pylori, is negatively associated with LTL.
Longitudinal studies are needed to assess the direction-
ality of the association and possible mechanisms
between infections and LTL.
Reduced LTL in relation to obesity, and longer LTL in
relation to physical activity were observed only in the bi-
variate analysis of the current study; such associations
were not significant in the multivariable models.
Smoking was not associated with LTL in our sample.
These observations confirm our previous report [15]
that was based on a sub-sample (n = 250) of the current
cohort. Of interest, short LTL was strongly and posi-
tively associated with the prevalence of asymptomatic
coronary atherosclerosis in that analysis [15].
Unlike previous findings [46], we found a negative
association between religiosity and LTL, which was
attenuated and became non-statistically significant in the
multiple linear regression model that adjusted for age
and sex. This suggests that the association between re-
ligiosity and LTL might result from confounding. Indeed,
more women than men reported being religious (Table
1), and also older than younger participants (see
Additional file 3).
Our study has some limitations. Using serum PGs to
study atrophic gastritis might have limited sensitivity,
which might result in non-differential misclassification of
atrophic gastritis. The directionality of the associations of
H. pylori sero-status and serological evidence of atrophic
gastritis with LTL remain unknown because of the cross-
sectional study design. Information on previous H. pylori
eradication therapy was not collected, given the nature of
our study, which utilized archived specimens and data that
were obtained in a study on cardiovascular risk factors
almost one decade ago. Persons with atrophic gastritis
might change their dietary habits, yet such information
was not available. Therefore, we cannot rule out the possi-
bility of residual confounders.
The response rate to participate in the original study
was 77% among Arabs; we cannot exclude the possibility
that the non-responders might have different character-
istics than the responders.
Our study has a number of strengths including the
large general population sample with the representation
of both sexes and various age groups, the attainment of
findings of broad generalizability, the comprehensive
assessment of demographic and lifestyle factors in
addition to H. pylori and serum PGs, and the adjustment
for confounders.
Conclusions
In this cross-sectional study, H. pylori IgG sero-positivity
per se was not related to shorter LTL. However, persons
lacking H. pylori IgG serum antibody with serological
evidence of atrophic gastritis had shorter LTL than did
those without atrophic gastritis, independent of other
factors that might affect LTL.
Methods
Study design and population
We used archived anonymized specimens obtained in the
framework of a cross-sectional study conducted during
2004-2008 among Jewish and Arab residents of Jerusalem.
Details of the study design have been reported [15, 42,
50–52]. The current study was limited to the Arab partici-
pants for whom LTL measurement was performed.
The sampling frame included all permanent residents
of East and West Jerusalem between ages 25–74 years,
as recorded in the Israeli National Population Register.
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Random samples were drawn from the register for both
population groups, stratified by sex and by 10-year age
groups, 200 names in each stratum, for a total of 2000
names and addresses in each population. These were all
invited to participate in the study. Individuals were ineli-
gible if they were unable to provide informed consent,
institutionalized, housebound, or had a severe illness;
and women, if they were pregnant or gave birth within
the 3 months preceding study initiation. The response
rate among Arabs was 77% (n = 970) [15, 50]. We did
not perform an a priori power calculation for the current
study; we used all the available serum samples, 934/970
representing 96.3% of the Arab participants in the
original study.
Data collection and definitions of the variables
Data were collected through personal interviews with
the participants conducted during 2004–2008. Informa-
tion was obtained on sex and age in years. Since the data
were collected during a 4-year period, we considered age
at examination, grouped here as 27–34, 35–44, 45–54,
55–64, and 65–78 years).
Self-reported education was classified into three cat-
egories: as having an academic degree, completed high
school, and did not complete high school [42, 50, 52].
Marital status was defined as being married or not mar-
ried (being single, divorced, or widowed). The variable
religiosity was assessed in view of previous reports link-
ing between religiosity and beneficial health outcomes
[53–55], and reports on associations between religiosity
and LTL [46]. Religiosity was defined based on the
participants’ reply to a single question: “How do you
define yourself?” The possible responses were very reli-
gious, religious, traditional, and secular. Since only two
participants defined themselves as very religious and
only 40 participants defined themselves as secular, the
responses were grouped into two categories: religious vs.
traditional/secular. Self-reported number of siblings was
defined as having 0–3, 4–7, or ≥ 8 siblings. Smoking was
classified as reported smoking of at least one cigarette
daily vs. no smoking/other (i.e., smoking less than one
cigarette/day). Physical activity was evaluated using the
Multi-Ethnic Study of Atherosclerosis questionnaire
[50], which assesses all-domains of physical activity in-
cluding leisure, transport, work, and at home. Physical
activity was defined following the World Health
Organization (WHO) recommendation for physical
activity in adults aged 18–64 years [56]. Participants
were classified as sufficiently physically active if they met
the WHO recommendation of doing at least 150 min of
at least moderate intensity aerobic physical activity; 75
min of at least vigorous physical activity or an equivalent
combination of moderate and vigorous intensity physical
activity of at least 600 metabolic equivalents (METs) mi-
nutes weekly [56]. Participants were classified as highly
active if they met the physical activity level associated
with health benefits (i.e., doing at least 300 min of mod-
erate-intensity aerobic activity throughout the week; or
doing at least 150 min of vigorous-intensity aerobic ac-
tivity; or an equivalent combination of moderate and
vigorous intensity physical activity of at least 1500 METs
minutes weekly). Height and weight were measured with
light clothing and without shoes. Weight in kilograms
was measured to the nearest 100 g using an analog scale.
Standing height was measured to the nearest 0.1 cm.
BMI was calculated as weight (in kg)/height (in meters
[m])2. Obesity was defined as BMI ≥ 30 kg/m2.
Laboratory methods
Sera were tested for the presence of specific H. pylori IgG
antibodies (Enzygnost® Anti-Helicobacter pylori II/IgG kit,
Siemens Diagnostics Product GmbH, Marburg, Germany).
The sensitivity and specificity of the kit are 94–98%. The
presence of IgG antibody against recombinant CagA pro-
tein was measured in H. pylori-positive sera following an
in-house ELISA protocol as previously described [42, 52,
57]. H. pylori sero-status was defined as (1) H. pylori nega-
tive if participants lacked H. pylori IgG antibody; (2) H.
pylori-positive CagA negative, if they had H. pylori IgG
antibody but lacked CagA IgG antibody; (3) H. pylori-
positive CagA positive if they had both H. pylori and CagA
IgG antibodies.
The level of serum PGI and PGII was quantified by
ELISA (Biohit Inc., Helsinki, Finland) and the ratio of
PGI:PGII was calculated. Serological evidence of atro-
phic gastritis was defined as a serum PGI level of < 30
μg/L or PGI:PGII ratio of < 3.0, as recommended by the
manufacturer. Participants were also classified according
to H. pylori IgG sero-positivity and serological evidence
of atrophic gastritis as (1) H. pylori negative, no atrophic
gastritis; (2) H. pylori positive, no atrophic gastritis; (3)
H. pylori positive plus atrophic gastritis; or (4) H. pylori
negative plus atrophic gastritis. Since atrophic gastritis is
caused mainly by H. pylori infection and severe gastric
atrophy results in loss of H. pylori infection [43], persons
who tested negative to H. pylori but had atrophic gastri-
tis were considered as having past H. pylori infection.
All serological assays were performed in one laboratory
at Tel University by an experienced technician who was
masked to the LTL results and information on the other
independent variables.
The measurement of LTL was performed using south-
ern blot analysis of the terminal restriction fragment
length at the laboratory of Professor Abraham Aviv, the
Center of Human Development and Aging, Rutgers, The
State University of New Jersey, New Jersey Medical
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School, Newark, USA [15, 49]. LTL (kb) was analyzed as
a continuous variable expressed in kilobase pair.
Statistical analysis
The study sample (overall and by sex) was described using
means (and standard deviations (SDs)) for continuous var-
iables, and frequency and percentages for categorical vari-
ables. Differences in mean LTL (kb) were examined using
the Student’s t test for dichotomous variables (i.e., sex, re-
ligiosity, marital status, physical activity, obesity, smoking)
and one-way analysis of variance (ANOVA) for categorical
variables with more than two categories (i.e., age, educa-
tion, number of siblings, and H. pylori sero-status/atrophic
gastritis). The Bonferroni post hoc test was used for pair-
wise comparisons to adjust for multiple comparisons. The
variable LTL followed approximately a normal distribu-
tion. The assumptions of equal variance in Student’s t test
and homogeneity of variance in ANOVA were examined
and met. These analyses were performed in stratification
by sex, given the documented difference between men
and women in LTL [8]. Interactions between sex and the
independent variables were assessed as an initial step
before running a pooled multivariable model.
Multiple linear regression models were fitted to assess
the associations between H. pylori sero-status/atrophic
gastritis and LTL while adjusting for demographic and
lifestyle factors. H. pylori sero-status/atrophic gastritis
was enforced into the model as the main independent
variable of interest. Other independent variables were
selected to be included in the model based on prior
knowledge; if the independent variables were associated
with LTL (age, sex [5, 7, 8], religiosity [46], education as
a measure of SES [23], smoking [24, 25], obesity [25],
and physical activity [27, 28]), or with H. pylori infection
(education and number of siblings [58]). Categorical var-
iables were included in the model as dummy variables.
Covariates were excluded from the analysis if they were
associated with LTL in the model with p > 0.2, and if
they yielded a change of less than 10% in the point
estimate [59] of the association between H. pylori sero-
status/atrophic gastritis and LTL (suggesting that they
were not confounders), or in the adjusted R2. This re-
sulted in two multivariable models, for each of them we
reported the p value, F statistics, and adjusted R2. Inter-
actions between H. pylori sero-status/atrophic gastritis
and the other independent variables were assessed in the
models. For each independent variable, we reported the
beta (slope) coefficient (and 95% CI) that were obtained
from these models. The assumptions of the linear re-
gressions were assessed and met in all models. Collinear-
ity between the independent variables was assessed
using VIF. Statistical significance was set at p < 0.05.
Data were analyzed using IBM SPSS version 25
(Armonk, NY, USA).
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